|
04 Sep 2025 |
Shree Cements
|
Consensus Share Price Target
|
29940.00 |
30904.33 |
- |
3.22 |
hold
|
|
|
|
|
16 May 2024
|
Shree Cements
|
ICICI Securities Limited
|
29940.00
|
27085.00
|
25685.60
(16.56%)
|
Target met |
Hold
|
|
|
Shree Cement’s (SRCM) Q4FY24 EBITDA/t, at INR 1,347, has yet again stood at the highest level among peers.
|
|
16 May 2024
|
Shree Cements
|
Axis Direct
|
29940.00
|
29350.00
|
25685.60
(16.56%)
|
Target met |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
16 May 2024
|
Shree Cements
|
IDBI Capital
|
29940.00
|
27088.00
|
25685.60
(16.56%)
|
Target met |
Hold
|
|
|
|
|
05 Feb 2024
|
Shree Cements
|
BP Wealth
|
29940.00
|
|
26954.80
(11.07%)
|
|
Results Update
|
|
|
|
|
03 Feb 2024
|
Shree Cements
|
BOB Capital Markets Ltd.
|
29940.00
|
27836.00
|
28453.95
(5.22%)
|
Target met |
Hold
|
|
|
Q3 revenue growth of 20% YoY backed by sharp 11% volume uptick to 8.9mt
|
|
01 Feb 2024
|
Shree Cements
|
Axis Direct
|
29940.00
|
31470.00
|
29613.55
(1.10%)
|
|
Buy
|
|
|
Recommendation: We roll over our estimate to FY26 and change our rating from HOLD to BUY on the back of strong operating performance.
|
|
01 Feb 2024
|
Shree Cements
|
IDBI Capital
|
29940.00
|
30069.00
|
29613.55
(1.10%)
|
Target met |
Hold
|
|
|
|
|
20 Nov 2023
|
Shree Cements
|
Geojit BNP Paribas
|
29940.00
|
28110.00
|
25953.65
(15.36%)
|
Target met |
Hold
|
|
|
|
|
09 Nov 2023
|
Shree Cements
|
BOB Capital Markets Ltd.
|
29940.00
|
24792.00
|
25951.40
(15.37%)
|
Target met |
Hold
|
|
|
Q2 volume growth of 10% YoY could have been higher but for a pursuit of realisation gains (+10%)
|
|
09 Nov 2023
|
Shree Cements
|
ICICI Securities Limited
|
29940.00
|
27117.00
|
26270.50
(13.97%)
|
Target met |
Hold
|
|
|
With an upbeat Q2FY24 performance, Shree Cement (SRCM) has reclaimed its industry supremacy. While reported EBITDA stood just 2% ahead of estimates, a closer look brings forth the following positives for its core cement business – a) ~2% QoQ uptick in realisation (vs it being flat for major peers) and b) ~3% QoQ rise in EBITDA/t (vs QoQ dip for other large peers).
|